R
Rapid Dose Therapeutics Corp
CNSX:DOSE
Rapid Dose Therapeutics Corp
CNSX:DOSE
Price:
0.14
CAD
Market Cap:
CA$18.7m
Balance Sheet
Balance Sheet Decomposition
Rapid Dose Therapeutics Corp
Rapid Dose Therapeutics Corp
Balance Sheet Decomposition is not available for
Rapid Dose Therapeutics Corp
Rapid Dose Therapeutics Corp
Balance Sheet
Rapid Dose Therapeutics Corp
Rapid Dose Therapeutics Corp
Currency: CAD
| Feb-2019 | Feb-2020 | Feb-2021 | Feb-2022 | Feb-2023 | Feb-2024 | Feb-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
4
|
0
|
1
|
1
|
0
|
1
|
1
|
|
| PP&E Net |
2
|
4
|
3
|
2
|
2
|
1
|
1
|
|
| PP&E Gross |
2
|
4
|
3
|
2
|
2
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
1
|
1
|
2
|
3
|
3
|
4
|
|
| Total Assets |
6
N/A
|
4
-26%
|
4
-11%
|
3
-20%
|
2
-27%
|
2
-16%
|
2
-13%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1
|
2
|
2
|
1
|
3
|
1
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1
|
0
|
0
|
0
|
3
|
|
| Other Current Liabilities |
1
|
2
|
2
|
0
|
1
|
0
|
0
|
|
| Total Current Liabilities |
2
|
3
|
5
|
2
|
5
|
3
|
7
|
|
| Long-Term Debt |
0
|
1
|
1
|
0
|
0
|
2
|
0
|
|
| Total Liabilities |
2
N/A
|
4
+127%
|
5
+22%
|
3
-48%
|
5
+75%
|
5
+3%
|
7
+36%
|
|
| Equity | ||||||||
| Common Stock |
17
|
18
|
19
|
25
|
25
|
27
|
28
|
|
| Retained Earnings |
13
|
18
|
20
|
29
|
33
|
35
|
40
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
4
|
5
|
5
|
7
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
4
N/A
|
0
N/A
|
2
-970%
|
0
N/A
|
3
N/A
|
3
-18%
|
5
-65%
|
|
| Total Liabilities & Equity |
6
N/A
|
4
-26%
|
4
-11%
|
3
-20%
|
2
-27%
|
2
-16%
|
2
-13%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
75
|
77
|
81
|
103
|
104
|
118
|
130
|
|
Switch to:
Switch to:
See Also
Discover More
